XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Income Statement [Abstract]        
Revenue $ 5,795 $ 2,749 $ 11,300 $ 5,194
Cost of sales (5,765) (1,739) (9,181) (2,944)
Gross margin 30 1,010 2,119 2,250
Research and development expenses 26,932 29,506 54,502 54,369
General and administrative expenses 16,323 11,968 31,018 22,488
Other expenses 12,896 12,202 28,192 21,907
Loss from operations (56,121) (52,666) (111,593) (96,514)
Sponsored cost share 16,337 25,172 34,210 45,749
Change in fair value of warrant liabilities 7,199 6,120 6,091 6,120
Interest income (expense) 2,851 (6) 5,948 (108)
Loss before income taxes (29,734) (21,380) (65,344) (44,753)
Provision (benefit) for income taxes 0 0 0 0
Net loss (29,734) (21,380) (65,344) (44,753)
Net loss attributable to legacy NuScale LLC holders prior to Transaction 0 (7,782) 0 (31,155)
Net loss attributable to noncontrolling interests (20,211) (11,005) (44,859) (11,005)
Net Loss Attributable to Class A Common Stockholders $ (9,523) $ (2,593) $ (20,485) $ (2,593)
Loss per Share of Class A Common Stock:        
Basic (usd per share) $ (0.13) $ (0.06) $ (0.29) $ (0.06)
Diluted (usd per share) $ (0.13) $ (0.06) $ (0.29) $ (0.06)
Weighted-Average Shares of Class A Common Stock Outstanding:        
Basic (shares) 72,125,375 42,028,341 70,913,646 42,028,341
Diluted (shares) 72,125,375 42,028,341 70,913,646 42,028,341